Accelrys Inc (ACCL) 12.51 $ACCL
33.6% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Wed May 07, 9:41AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 8 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
Dassault Systemes completes Accelrys tender offer
M2 - Wed Apr 30, 11:43AM CDT
Dassault Systemes (DSY.PA) said it has completed the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp., to purchase all of the outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes.
Dassault Systemes Successfully Completes Acquisition of Accelrys
Business Wire - Tue Apr 29, 12:45PM CDT
Regulatory News:
Dassault Systemes announces successful completion of Accelrys tender offer
M2 - Tue Apr 29, 4:33AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today the completion of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all of the outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes.
Dassault Systemes Successfully Completes Tender Offer for Accelrys
Business Wire - Tue Apr 29, 3:02AM CDT
Regulatory News:
Pierre Fabre Laboratories Selects QUMAS DocCompliance to Manage Quality Documents Across Entire Organization
Marketwire - Mon Apr 28, 6:29AM CDT
QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that Pierre Fabre Laboratories, a leading pharmaceutical and cosmetics company with headquarters in Castres, France, has selected QUMAS DocCompliance to manage and control quality documents across the entire company. The QUMAS Compliance Platform was selected after an extensive evaluation process conducted by members of the Quality Assurance and IT teams at Pierre Fabre Laboratories. The QUMAS solution will be rolled out to 3,850 Pierre Fabre employees initially.
Dassault Systemes' proposed acquisition of Accelrys cleared by CFIUS
M2 - Fri Apr 25, 6:07AM CDT
Dassault Systemes (Paris SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced on Thursday that the Committee on Foreign Investment in the United States (CFIUS) has completed its investigation of the acquisition of Accelrys Inc (Nasdaq:ACCL) by Dassault Systemes and determined that there are no unresolved national security concerns with the proposed acquisition.
Dassault Systemes extends Accelrys offer till April 28
M2 - Thu Apr 24, 6:41AM CDT
Dassault Systemes said it has extended the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp., to purchase all outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash.
Proposed Acquisition of Accelrys by Dassault Systemes Cleared by CFIUS
Business Wire - Thu Apr 24, 12:34AM CDT
Regulatory News:
Global In-vitro Toxicity Testing Market 2014-2018 with Accelrys, Bio-Rad Laboratories, Charles River Laboratories International & Covance Dominating
M2 - Wed Apr 23, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/p7txnm/global_invitro) has announced the addition of the "Global In-vitro Toxicity Testing Market 2014-2018" report to their offering. The analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. The Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Animal welfare organizations across the world are supporting in vitro toxicity testing. Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as cruelty-free food, cosmetics, and clothing as cruelty-free testing does not damage the environment or produce harmful waste. For instance, the Body Shop follows a no-animal-tests policy to sell its products. Thus, the increase in animal-free testing campaigns has opened up new avenues for the market. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The Global In Vitro Toxicity Testing market can be divided into four end-user segments: - Cosmetics and Personal Care Industry - Pharmaceuticals Industry - Food Industry - Chemicals Industry. Key Vendors - Accelrys Inc. - Bio-Rad Laboratories Inc. - Charles River Laboratories International Inc. - Covance Inc. Other Prominent Vendors - Entelos Inc. - Mattek Corp. - Molecular Toxicology Inc. - RTI Health Solutions - SBW Ltd. - Smithers Group Inc. - Xenobiotic Detection Systems Inc. - Xenometrix AG Key Market Drivers/Challenges/Trends - Increasing Opposition to Animal Testing. - Concerns about Accuracy and Reliability of the Test. - Increase in Animal-free Testing Campaigns. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Toxicology - Market Landscape - Market Segmentation by End-users - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/p7...al_invitro
Dassault Systemes announces extension of tender offer for outstanding Accelrys shares until 28 April 2014
M2 - Wed Apr 23, 8:15AM CDT
Dassault Systemes (Paris: DSY.PA), a provider in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (ACCL) (Accelrys) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes.
Dassault Systemes Extends Tender Offer for Accelrys until April 28, 2014
Business Wire - Wed Apr 23, 12:17AM CDT
Regulatory News:
Accelrys Up 33.5% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Tue Apr 22, 4:50PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.48% as of today's recent price of $12.50.
New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery
PR Newswire - Thu Apr 17, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the availability of two new mobile applications supporting key life sciences workflows and real-time collaboration spanning both the ScienceCloud workspace and on-premises systems. ScienceCloud is a secure, SaaS-based, mobile-enabled information management and collaboration environment that improves data and knowledge sharing for globally networked researchers. Bi-directional integration between ScienceCloud and existing on-premises systems lets life sciences organizations migrate to the cloud in a measured fashion, continuing to leverage critical legacy applications as long as needed.
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
In Vitro Toxicity Testing to Grow at a 15.84% CAGR to 2018 Says a New Research Report at ReportsnReports.com
PRWeb - Mon Apr 14, 2:58AM CDT
Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as Cruelty-free food Cosmetics And clothing as cruelty-free testing does not damage the environment or produce harmful waste. Analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. According to the report, the Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Covered in this Report The Global In Vitro Toxicity Testing market can be divided into four end-user segments: Cosmetics and Personal Care Industry, Pharmaceuticals Industry, Food Industry, and Chemicals Industry. The Global In Vitro Toxicity Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global In Vitro Toxicity Testing market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Accelrys Inc. Bio-Rad Laboratories Inc. Charles River Laboratories International Inc. Covance Inc. Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=280671. Other Prominent Vendors Entelos Inc. Mattek Corp. Molecular Toxicology Inc. RTI Health Solutions SBW Ltd. Smithers Group Inc. Xenobiotic Detection Systems Inc. Xenometrix AG Key Market Driver Increasing Opposition to Animal Testing. Key Market Challenge Concerns about Accuracy and Reliability of the Test. Key Market Trend Increase in Animal-free Testing Campaigns. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The report recognizes the following companies as the key players in Global In-vitro Toxicity Testing Market: Accelrys Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc. , Covance Inc. , Entelos Inc., MattekCorp., Molecular Toxicology Inc., RTI Health Solutions, SBW Ltd., Smithers Group Inc., Xenobiotic Detection SystemsInc., Xenometrix AG. Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Accelrys® Speeds Life Science Decisions with Next-Generation Insight®
PR Newswire - Thu Apr 10, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the latest releases of Accelrys Insight and Accelrys Insight for Excel. The new release of Accelrys Insight for Excel enhances scientific data analysis with important new capabilities including the ability to run database searches directly from the familiar Microsoft Excel spreadsheet environment. The new release of the web-based Accelrys Insight life science, discovery and innovation support environment speeds decisions by simplifying access to complex hierarchical data and implementing data-rich tooltips for scatterplots. The two releases continue the rapid evolution of Accelrys' next-generation solution for interactively searching, browsing and visualizing data within the Accelrys Cheminformatics Suite, helping networked life science discovery teams bring innovative therapeutics to market faster and more cost effectively. Both products leverage the open, scientifically aware Accelrys Enterprise Platform which provides a single consistent way for applications to access both internal data and public data accessible via web services.
Dassault Systemes announces extension of tender offer for Accelrys' shares until 22 April 2014
M2 - Wed Apr 09, 11:07AM CDT
Dassault Systemes (Paris SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock until midnight, New York City time of 22 April 2014, unless otherwise extended or terminated.
33.6% Return Seen to Date on SmarTrend Accelrys Call (ACCL)
Comtex SmarTrend(R) - Wed May 07, 9:41AM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 8 months, Accelrys has returned 33.58% as of today's recent price of $12.51.
Dassault Systemes completes Accelrys tender offer
M2 - Wed Apr 30, 11:43AM CDT
Dassault Systemes (DSY.PA) said it has completed the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp., to purchase all of the outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes.
Dassault Systemes Successfully Completes Acquisition of Accelrys
Business Wire - Tue Apr 29, 12:45PM CDT
Regulatory News:
Dassault Systemes announces successful completion of Accelrys tender offer
M2 - Tue Apr 29, 4:33AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today the completion of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all of the outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes. Dassault Systemes Successfully Completes Tender Offer for Accelrys
Business Wire - Tue Apr 29, 3:02AM CDT
Regulatory News:
Pierre Fabre Laboratories Selects QUMAS DocCompliance to Manage Quality Documents Across Entire Organization
Marketwire - Mon Apr 28, 6:29AM CDT
QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that Pierre Fabre Laboratories, a leading pharmaceutical and cosmetics company with headquarters in Castres, France, has selected QUMAS DocCompliance to manage and control quality documents across the entire company. The QUMAS Compliance Platform was selected after an extensive evaluation process conducted by members of the Quality Assurance and IT teams at Pierre Fabre Laboratories. The QUMAS solution will be rolled out to 3,850 Pierre Fabre employees initially.
Dassault Systemes' proposed acquisition of Accelrys cleared by CFIUS
M2 - Fri Apr 25, 6:07AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced on Thursday that the Committee on Foreign Investment in the United States (CFIUS) has completed its investigation of the acquisition of Accelrys Inc (Nasdaq:ACCL) by Dassault Systemes and determined that there are no unresolved national security concerns with the proposed acquisition. Dassault Systemes extends Accelrys offer till April 28
M2 - Thu Apr 24, 6:41AM CDT
Dassault Systemes said it has extended the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp., to purchase all outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) common stock at an offer price of USD12.50 per share in cash.
Proposed Acquisition of Accelrys by Dassault Systemes Cleared by CFIUS
Business Wire - Thu Apr 24, 12:34AM CDT
Regulatory News:
Global In-vitro Toxicity Testing Market 2014-2018 with Accelrys, Bio-Rad Laboratories, Charles River Laboratories International & Covance Dominating
M2 - Wed Apr 23, 9:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/p7txnm/global_invitro) has announced the addition of the "Global In-vitro Toxicity Testing Market 2014-2018" report to their offering. The analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. The Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Animal welfare organizations across the world are supporting in vitro toxicity testing. Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as cruelty-free food, cosmetics, and clothing as cruelty-free testing does not damage the environment or produce harmful waste. For instance, the Body Shop follows a no-animal-tests policy to sell its products. Thus, the increase in animal-free testing campaigns has opened up new avenues for the market. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The Global In Vitro Toxicity Testing market can be divided into four end-user segments: - Cosmetics and Personal Care Industry - Pharmaceuticals Industry - Food Industry - Chemicals Industry. Key Vendors - Accelrys Inc. - Bio-Rad Laboratories Inc. - Charles River Laboratories International Inc. - Covance Inc. Other Prominent Vendors - Entelos Inc. - Mattek Corp. - Molecular Toxicology Inc. - RTI Health Solutions - SBW Ltd. - Smithers Group Inc. - Xenobiotic Detection Systems Inc. - Xenometrix AG Key Market Drivers/Challenges/Trends - Increasing Opposition to Animal Testing. - Concerns about Accuracy and Reliability of the Test. - Increase in Animal-free Testing Campaigns. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Toxicology - Market Landscape - Market Segmentation by End-users - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/p7...al_invitro
Dassault Systemes announces extension of tender offer for outstanding Accelrys shares until 28 April 2014
M2 - Wed Apr 23, 8:15AM CDT
Dassault Systemes (Paris: DSY.PA), a provider in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, announced today the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (ACCL) (Accelrys) common stock at an offer price of USD12.50 per share in cash, without interest and subject to any required withholding of taxes.
Dassault Systemes Extends Tender Offer for Accelrys until April 28, 2014
Business Wire - Wed Apr 23, 12:17AM CDT
Regulatory News:
Accelrys Up 33.5% Since SmarTrend Uptrend Call (ACCL)
Comtex SmarTrend(R) - Tue Apr 22, 4:50PM CDT
SmarTrend identified an Uptrend for Accelrys (NASDAQ:ACCL) on September 16th, 2013 at $9.37. In approximately 7 months, Accelrys has returned 33.48% as of today's recent price of $12.50.
New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug Discovery
PR Newswire - Thu Apr 17, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the availability of two new mobile applications supporting key life sciences workflows and real-time collaboration spanning both the ScienceCloud workspace and on-premises systems. ScienceCloud is a secure, SaaS-based, mobile-enabled information management and collaboration environment that improves data and knowledge sharing for globally networked researchers. Bi-directional integration between ScienceCloud and existing on-premises systems lets life sciences organizations migrate to the cloud in a measured fashion, continuing to leverage critical legacy applications as long as needed.
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
In Vitro Toxicity Testing to Grow at a 15.84% CAGR to 2018 Says a New Research Report at ReportsnReports.com
PRWeb - Mon Apr 14, 2:58AM CDT
Cosmetic as well as chemical companies are trying to market and sell their products by campaigning animal-free testing. Popular brands of cosmetics are implementing animal-free testing policies to market and sell their products. Vendors are targeting compassionate consumers by marketing their products as Cruelty-free food Cosmetics And clothing as cruelty-free testing does not damage the environment or produce harmful waste. Analysts forecast the Global In Vitro Toxicity Testing market will grow at a CAGR of 15.84 percent over the period 2013-2018. According to the report, the Global In Vitro Toxicity Testing market is driven by several factors, of which an increase in opposition to animal testing is one of the major drivers. Since animals are used as test subjects, toxicity testing is opposed by the majority of animal rights activists. This results in the increased adoption of in vitro toxicity testing and helps in the growth of the market. Covered in this Report The Global In Vitro Toxicity Testing market can be divided into four end-user segments: Cosmetics and Personal Care Industry, Pharmaceuticals Industry, Food Industry, and Chemicals Industry. The Global In Vitro Toxicity Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global In Vitro Toxicity Testing market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The report also includes a discussion of the key vendors operating in this market. Key Regions Americas EMEA APAC Key Vendors Accelrys Inc. Bio-Rad Laboratories Inc. Charles River Laboratories International Inc. Covance Inc. Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=280671. Other Prominent Vendors Entelos Inc. Mattek Corp. Molecular Toxicology Inc. RTI Health Solutions SBW Ltd. Smithers Group Inc. Xenobiotic Detection Systems Inc. Xenometrix AG Key Market Driver Increasing Opposition to Animal Testing. Key Market Challenge Concerns about Accuracy and Reliability of the Test. Key Market Trend Increase in Animal-free Testing Campaigns. Further, the report states that the accuracy and reliability of in vitro toxicity testing is one of the major challenges faced by the market vendors. In vitro toxicity testing requires proper laboratory setup as well as high-quality cell and tissue culture and good aseptic techniques. The report recognizes the following companies as the key players in Global In-vitro Toxicity Testing Market: Accelrys Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc. , Covance Inc. , Entelos Inc., MattekCorp., Molecular Toxicology Inc., RTI Health Solutions, SBW Ltd., Smithers Group Inc., Xenobiotic Detection SystemsInc., Xenometrix AG. Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Accelrys® Speeds Life Science Decisions with Next-Generation Insight®
PR Newswire - Thu Apr 10, 7:00AM CDT
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software and solutions, today announced the latest releases of Accelrys Insight and Accelrys Insight for Excel. The new release of Accelrys Insight for Excel enhances scientific data analysis with important new capabilities including the ability to run database searches directly from the familiar Microsoft Excel spreadsheet environment. The new release of the web-based Accelrys Insight life science, discovery and innovation support environment speeds decisions by simplifying access to complex hierarchical data and implementing data-rich tooltips for scatterplots. The two releases continue the rapid evolution of Accelrys' next-generation solution for interactively searching, browsing and visualizing data within the Accelrys Cheminformatics Suite, helping networked life science discovery teams bring innovative therapeutics to market faster and more cost effectively. Both products leverage the open, scientifically aware Accelrys Enterprise Platform which provides a single consistent way for applications to access both internal data and public data accessible via web services.
Dassault Systemes announces extension of tender offer for Accelrys' shares until 22 April 2014
M2 - Wed Apr 09, 11:07AM CDT
Dassault Systemes (Paris
SY.PA), a provider of 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp, to purchase all outstanding shares of Accelrys Inc (Nasdaq:ACCL) common stock until midnight, New York City time of 22 April 2014, unless otherwise extended or terminated. 
